Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target.
Hiemcke-Jiwa LS, Meister MT, Martin E, Dierselhuis MP, Haveman LM, Meijers RWJ, Tops BBJ, Wesseling P, van Diest PJ, van Gorp JM, Hehir-Kwa JY, van Belzen IAEM, Bonenkamp JJ, van Noesel MM, Flucke U, Kester LA. Hiemcke-Jiwa LS, et al. Among authors: wesseling p. Acta Neuropathol. 2023 Jan;145(1):149-152. doi: 10.1007/s00401-022-02515-3. Epub 2022 Nov 4. Acta Neuropathol. 2023. PMID: 36331594 Free PMC article. No abstract available.
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A. Hartmann C, et al. Among authors: wesseling p. Acta Neuropathol. 2009 Oct;118(4):469-74. doi: 10.1007/s00401-009-0561-9. Epub 2009 Jun 25. Acta Neuropathol. 2009. PMID: 19554337 Free article.
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis.
Tietze A, Bison B; European Society for Paediatric Oncology (SIOPE)-Brain Tumour Group; Engelhardt J, Fenouil T, Figarella-Branger D, Goebell E, Hakumäki J, Koscielniak E, Ludlow LE, Meyronet D, Nyman P, Øra I, Pesola J, Rauramaa T, Reddingius RE, Samuel D, Sexton-Oates A, Vasiljevic A, Wefers AK, Zamecnik J, Jones D, Keck MK, von Hoff K. Tietze A, et al. AJNR Am J Neuroradiol. 2024 Sep 13:ajnr.A8496. doi: 10.3174/ajnr.A8496. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39271290
Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rudà R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M; EANO Guidelines Committee and ESMO Guidelines Committee. Electronic address: [email protected]. Le Rhun E, et al. Among authors: wesseling p. ESMO Open. 2023 Oct;8(5):101624. doi: 10.1016/j.esmoop.2023.101624. Epub 2023 Sep 19. ESMO Open. 2023. PMID: 37863528 Free PMC article.
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype.
Tauziède-Espariat A, Friker LL, Nussbaumer G, Bison B, Dangouloff-Ros V, Métais A, Sumerauer D, Zamecnik J, Benesch M, Perwein T, van Vuurden D, Wesseling P, La Madrid AM, Garrè ML, Antonelli M, Giangaspero F, Pietsch T, Sturm D, Jones DTW, Pfister SM, Grabovska Y, Mackay A, Jones C, Grill J, Ajlil Y, von Bueren AO, Karremann M, Hoffmann M, Kramm CM, Kwiecien R, Castel D, Gielen GH, Varlet P. Tauziède-Espariat A, et al. Among authors: wesseling p. Acta Neuropathol Commun. 2024 Nov 18;12(1):176. doi: 10.1186/s40478-024-01881-1. Acta Neuropathol Commun. 2024. PMID: 39558399
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection - Update 1.
van den Bent MJ, Franceschi E, Touat M, French PJ, Idbaih A, Lombardi G, Rudaà R, Schweizer L, Capper D, Sanson M, Wesseling P, Weller M, Eoli M, Anghileri E, Bielle F, Euskirchen P, Geurts M, Wen PY, Preusser M. van den Bent MJ, et al. Among authors: wesseling p. Neuro Oncol. 2024 Oct 10:noae213. doi: 10.1093/neuonc/noae213. Online ahead of print. Neuro Oncol. 2024. PMID: 39387386
cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.
Sahm F, Aldape KD, Brastianos PK, Brat DJ, Dahiya S, von Deimling A, Giannini C, Gilbert MR, Louis DN, Raleigh DR, Reifenberger G, Santagata S, Sarkar C, Zadeh G, Wesseling P, Perry A. Sahm F, et al. Among authors: wesseling p. Neuro Oncol. 2024 Aug 30:noae170. doi: 10.1093/neuonc/noae170. Online ahead of print. Neuro Oncol. 2024. PMID: 39212325
Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors.
Metselaar DS, Meel MH, Goulding JR, du Chatinier A, Rigamonti L, Waranecki P, Geisemeyer N, de Gooijer MC, Breur M, Koster J, Veldhuijzen van Zanten SEM, Bugiani M, Franke NE, Reddy A, Wesseling P, Kaspers GJL, Hulleman E. Metselaar DS, et al. Among authors: wesseling p. Cell Rep Med. 2024 Sep 17;5(9):101700. doi: 10.1016/j.xcrm.2024.101700. Epub 2024 Aug 28. Cell Rep Med. 2024. PMID: 39208799 Free PMC article.
369 results